Literature DB >> 3210022

Human immunodeficiency virus infection of the brain. I. Virus isolation and detection of HIV specific antibodies in the cerebrospinal fluid of patients with varying clinical conditions.

F Chiodi1, A Sönnerborg, J Albert, H Gaines, G Norkrans, L Hagberg, B Asjö, O Strannegård, E M Fenyö.   

Abstract

Isolation of the human immunodeficiency virus (HIV) has been attempted from the cerebrospinal fluid (CSF) of 29 subjects with varying severity of HIV infection. Virus could be isolated from patients in all stages of disease including patients with primary HIV infection and asymptomatic carriers. In the early stages of infection free virus was infrequently present in the CSF but could be isolated from the cells present in CSF. This suggests that HIV may reach the brain at a very early stage of infection and that initially there is little production of virus from infected cells. In the late stages of HIV infection, associated with increasing severity of immunodeficiency, free virus could readily be isolated from the CSF. With one exception, all of these patients had neurological and/or psychiatric symptoms, as compared to only 2 (of 13) subjects in the early stages of infection. All patients with HIV-specific antibodies in serum had antibodies also in CSF. Examined by a radioimmunoprecipitation assay, CSF was more often found to contain antibodies to the precursor (p55) of viral core proteins than the corresponding serum of the patients. We propose that immune disturbances have an essential pathogenic role in the neurological/psychiatric symptoms associated with HIV infection, possibly through allowing increased viral expression in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3210022     DOI: 10.1016/0022-510x(88)90184-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

1.  Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.

Authors:  Elham Rahimy; Fang-Yong Li; Lars Hagberg; Dietmar Fuchs; Kevin Robertson; Dieter J Meyerhoff; Henrik Zetterberg; Richard W Price; Magnus Gisslén; Serena Spudich
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

Review 2.  The pathogenesis of the neurological complications of HIV-1 infection.

Authors:  B J Brew
Journal:  Genitourin Med       Date:  1993-10

3.  Cerebrospinal fluid HIV-1 p24 antigen and culture: sensitivity and specificity for AIDS-dementia complex.

Authors:  B J Brew; M O Paul; G Nakajima; A Khan; H Gallardo; R W Price
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

4.  Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden.

Authors:  Serena Spudich; Magnus Gisslen; Lars Hagberg; Evelyn Lee; Teri Liegler; Bruce Brew; Dietmar Fuchs; Giuseppe Tambussi; Paola Cinque; Frederick M Hecht; Richard W Price
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

5.  Structural gray matter change early in male patients with HIV.

Authors:  Yunfang Li; Hongjun Li; Quansheng Gao; Da Yuan; Jing Zhao
Journal:  Int J Clin Exp Med       Date:  2014-10-15

6.  Increased blood-brain barrier permeability in neuro-asymptomatic HIV-1-infected individuals--correlation with cerebrospinal fluid HIV-1 RNA and neopterin levels.

Authors:  L M Andersson; L Hagberg; D Fuchs; B Svennerholm; M Gisslén
Journal:  J Neurovirol       Date:  2001-12       Impact factor: 2.643

Review 7.  Cerebrospinal fluid (CSF) analyses in HIV-1 primary neurological disease.

Authors:  J Nogales-Gaete; K Syndulko; W W Tourtellotte
Journal:  Ital J Neurol Sci       Date:  1992-11

8.  Predictive value of neurological abnormalities in HIV 1 patients in the early stages of the infection.

Authors:  G Tilia; M Spadaro; G Soldati; E Pinter; C Morocutti
Journal:  Ital J Neurol Sci       Date:  1993-03

9.  Structural brain alterations can be detected early in HIV infection.

Authors:  Ann B Ragin; Hongyan Du; Renee Ochs; Ying Wu; Christina L Sammet; Alfred Shoukry; Leon G Epstein
Journal:  Neurology       Date:  2012-11-28       Impact factor: 9.910

10.  Matrix metalloproteinase levels in early HIV infection and relation to in vivo brain status.

Authors:  Suyang Li; Ying Wu; Sheila M Keating; Hongyan Du; Christina L Sammet; Cindy Zadikoff; Riti Mahadevia; Leon G Epstein; Ann B Ragin
Journal:  J Neurovirol       Date:  2013-08-27       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.